Skip to main content
Earnings Labs
Prothena Corporation plc logo

Prothena Corporation plc (PRTA)

NASDAQ·Healthcare·Biotechnology

$8.54

+2.52%

Mkt Cap $425.11M

Analyst Ratings

No recent rating data.

Price Target (15 analysts)

$24.50

Range $19.00$30.00

Implied Upside

+186.9%

Consensus $24.50 vs current $8.54